Astrazeneca's Evp On The Potential Of The Pharma Giant's New Breast Cancer Drug

AstraZeneca's EVP on the potential of the pharma giant's new breast cancer drug

CNBC International News

AstraZeneca's Precision Drug for Breast Cancer Fails to Improve Survival in Key Trial

WNO

METASTATIC BREAST CANCER: ENHERTU STOPS THE SPREAD

AstraZeneca's experimental drug disappoints in breast cancer survival trial

AstraZeneca cancer drug prolongs survival

AstraZeneca CEO Pascal Soriot breaks down data on new 'transformative' breast cancer drug

CNBC Television

AstraZeneca reports positive results in prostate cancer trial, AstraZeneca oncology unit EVP says

CNBC International News

Ashley Gaines - VP, Head of #BreastCancer Franchise, US Oncology Business Unit, #AstraZeneca

Progress, Potential, and Possibilities

AstraZeneca - Next-Generation Therapies Advancing Cancer Care

HPR

ENHERTU Therapy: A Powerful New Cancer Treatment

Cancer Informant

DCGI Nod To AstraZeneca India Breast Cancer Drug Lynparza

Medical Dialogues

'Tumors just vanished': Cancer patients now in remission after drug trial

CNN

Turning the Tide on Breast Cancer

ENHERTU: METASTATIC BREAST CANCER DRUG GRANTS TICA’S WISH

AstraZeneca CEO: Objective is to replace chemotherapy

CNBC International News

Hope on the horizon: New breast cancer drug shown to slow tumor progression

AstraZeneca Faces Setback in Drug Trial for Breast Cancer Treatment

New breast cancer drug delivers unprecedented levels of survival, stopping tumor growth

ENHERTU – Metastatic Breast Cancer Drug Grants Tica’s Wish

Dave Fredrickson, EVP Oncology Business Unit, AstraZeneca, talks about Ovarian Cancer Commitment

ESGO - European Society of Gynaecological Oncology